Skip to main content
. 2021 Nov 4;9(1):155–163. doi: 10.1002/ehf2.13665

Table 5.

Add. heart failure‐related hospitalization (as treated population stratified by sacubitril/valsartan)

Event Sacubitril/valsartan Relative risk (95% CI) Relative rate (95% CI)
Yes (N = 68) No (N = 164)
# Patient (%) # Events (EPPY) # Patient (%) # Events (EPPY)
Heart failure hospitalizations 27 (39.7%) 37 (0.55) 64 (39.0%) 100 (0.66) 1.0 (0.8, 1.2) 0.8 (0.6, 1.2)

CI, confidence interval; EPPY, events per patient year.